In advance of an upcoming meeting on regional trade, the U.S. trade representative urged the Colombian government to overhaul various practices for making medicines available, a topic that has increasingly angered the U.S. pharmaceutical industry.

In a Feb. 14 letter, Robert Lighthizer wrote to the Colombian trade minister that “key stakeholders remain dissatisfied” with government policies. The letter was sent as a meeting nears this month, according to sources, to discuss membership in the Organization for Economic Cooperation and Development, an intergovernmental group of three dozen countries that was created to stimulate economic progress and world trade.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy